Nascobal Articles
AMD risk reduced by Vit B and folic acid
2 March 2009
Cobalis partners with MDC for PreHistin
26 January 2009
Meda to acquire Recip for $407M+
5 November 2007
Nastech sees 311% income surge in 2005
27 March 2006
Nastech's Nascobal gets FDA approval
7 February 2005
BioGentech changes name to Cobalis
26 July 2004
Nascobal Nasal spray NDA submitted to FDA
5 January 2004
Nascobal use extended, but Schwarz deal ended
8 July 2002
Nasal vitamin B12 drug cleared in Sweden
28 January 2002
Cambridge Licenses Nasal Vitamin B12
12 August 1998
Nastech's Nascobal Cleared In USA
18 November 1996
PROF ALEXANDRE HEADS CPMP MEETING
27 September 1993
Showing 1-12 of 12 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
